Clinical Trial Update: Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating bevacizumab in severe or critical COVID-19 pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infections

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Coronavirus Infections | Phase 2 | Status: COMPLETED